BN Sullivan, MA Baggett, SS O'Connell, KM Pickett… - Journal of Fungi, 2022 - mdpi.com
Disseminated disease following invasive pulmonary aspergillosis (IPA) remains a significant contributor to mortality amongst patients with hematologic malignancies (HMs). At the …
SF Dufresne, DC Cole, DW Denning… - European Journal of …, 2017 - Springer
There are currently no nationwide epidemiological data on fungal infections in Canada. We estimated the burden of serious fungal diseases using literature review and modeling, as …
The purpose of the present study is to estimate the current incidence of febrile events (FEs) and infectious episodes in acute lymphoblastic leukemia (ALL) and evaluate the outcome …
M Salehi, N Shahrbaf, F Shahi… - Jundishapur Journal of …, 2023 - brieflands.com
Background: The incidence of invasive aspergillosis (IA) has significantly increased in recent decades. In patients with hematologic malignancies (HM), IA is associated with …
O Kassar, AB Kahla, Y Fakhefakh, W Feki… - La Tunisie …, 2024 - pmc.ncbi.nlm.nih.gov
Introduction: L'aspergillose pulmonaire invasive est une complication redoutable en hématologie. Objectif: Décrire les aspects diagnostiques, thérapeutiques et évolutives de …
O Kassar, B Kahla, Y Fakhefakh, W Feki… - La Tunisie …, 2024 - europepmc.org
Aim Describe the prevalence, diagnostic aspects, therapeutic modalities, and evolution of the IPA cases occurring in patients with acute leukemia. Methods Our study was …
SF Dufresne, J Bergeron… - Journal of the …, 2023 - jammi.utpjournals.press
Background: Patients undergoing remission-induction intensive chemotherapy for acute leukemia are at high risk for life-threatening invasive fungal infections (IFIs). Primary …
Exposure of immunosuppressed individuals to the opportunistic fungal pathogen Aspergillus (A.) fumigatus may result in invasive pulmonary aspergillosis (IPA), which could lead to the …
K Charoenprasert - Journal of Hematology and Transfusion Medicine, 2018 - tsh.or.th
Background: Invasive aspergillosis can be found among patients with acute leukemia who have prolonged neutropenia during intensive chemotherapy, resulting in poor outcome and …